Several groups have already used soluble CD40L, Il-2, IL-4, IL-10, IL15 or IL-21, isolated or in combination, to stimulate CLL cells22–24,30,34,39. This evidence concerns the gene IL10 and B-cell chronic lymphocytic leukemia.